Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

• 主要な著者: Tadesse Asmamaw Dejenie (著者), Markeshaw Tiruneh G/Medhin (著者), Gashaw Dessie Terefe (著者), Fitalew Tadele Admasu (著者), Wondwossen Wale Tesega (著者), Endeshaw Chekol Abebe (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a 'living' and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CA...